Alkermes ALKS
NASDAQ ALKS
$45.43 -0.06 (-0.13%)
As of: Sep 9, 2026 · 1:23 PM EDT

Alkermes (ALKS) Tax Provisions (2010 - 2026)

Alkermes' (ALKS) quarterly Tax Provisions came in at -$2.4 million in Q2 2026, down 113.53% year-over-year from $17.7 million in Q2 2025, and down 152.17% quarter-over-quarter from $4.6 million in Q1 2026.

Analysis

Alkermes (ALKS) Tax Provisions (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has reported Tax Provisions for 17 consecutive years, with -$2.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Tax Provisions fell 113.53% year-over-year to -$2.4 million in Q2 2026; TTM through Jun 2026 was $31.2 million, a 49.95% decrease from a year earlier, with the FY2025 full-year figure at $49.8 million, down 30.48% from the prior year.
  • Tax Provisions was -$2.4 million for Q2 2026 at Alkermes, down from $4.6 million in the prior quarter.
  • Over five years, Tax Provisions peaked at $26.8 million in Q4 2022 and troughed at -$102.2 million in Q4 2023.
  • A 5-year average of $2.1 million and a median of $3.8 million in 2025 frame the typical range for Tax Provisions.
  • Across the five-year window, Tax Provisions soared 1373.42% in 2022 and sank 481.88% in 2023, its largest moves.
  • Over 5 years, Tax Provisions stood at $26.8 million in 2022, then slumped by 481.88% to -$102.2 million in 2023, then surged by 123.58% to $24.1 million in 2024, then sank by 54.44% to $11.0 million in 2025, then tumbled by 121.85% to -$2.4 million in 2026.
  • The last three Tax Provisions figures came in at -$2.4 million (Q2 2026), $4.6 million (Q1 2026), and $11.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 644.32 Bn 623.56 Bn 17.26 Bn 1.21 Bn
2 AbbVie 440.60 Bn 434.04 Bn 12.70 Bn 662.00 Mn
3 Merck 365.39 Bn 358.25 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn -1.01 Bn
5 Pfizer 159.22 Bn 147.52 Bn 10.94 Bn -407.00 Mn
6 Sanofi 52.48 Bn 45.10 Bn 10.79 Bn -524.23 Mn
7 Revolution Medicines 44.21 Bn 44.21 Bn - -
8 Incyte 25.34 Bn 20.81 Bn 1.57 Bn 165.91 Mn
9 United Therapeutics 21.49 Bn 18.82 Bn 683.80 Mn 39.70 Mn
10 Alkermes 7.58 Bn 6.93 Bn 397.90 Mn -2.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.40 Mn
Mar 31, 2026 4.60 Mn
Dec 31, 2025 10.99 Mn
Sep 30, 2025 18.00 Mn
Jun 30, 2025 17.74 Mn
Mar 31, 2025 3.03 Mn
Dec 31, 2024 24.11 Mn
Sep 30, 2024 17.44 Mn
Jun 30, 2024 22.10 Mn
Mar 31, 2024 8.00 Mn
Dec 31, 2023 -102.24 Mn
Sep 30, 2023 1.20 Mn
Jun 30, 2023 2.73 Mn
Mar 31, 2023 717,000.00
Dec 31, 2022 26.77 Mn
Sep 30, 2022 -3.39 Mn
Jun 30, 2022 -3.11 Mn
Mar 31, 2022 -9.10 Mn
Dec 31, 2021 1.82 Mn
Sep 30, 2021 2.45 Mn